Physician profile
Mark Reginato
NPI 1194884502
$21,737.32
in general payments reported to CMS, 2019-2025
97 companies · $3,389 in 2025
The $3,389 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,865 · 2020: $2,057 · 2021: $3,832 · 2022: $3,034 · 2023: $3,241 · 2024: $3,319 · 2025: $3,389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,932 · Education: $17.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,932.07 |
| Education | $17.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,864.67 | 2019-2025 | |
| Pfizer INC. | $1,584.28 | 2019-2025 | |
| Amgen INC. | $1,173.49 | 2019-2025 | Otezla, Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $918.84 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Glaxosmithkline, LLC. | $822.60 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Esperion Therapeutics, INC. | $719.13 | 2020-2025 | Nexletol |
| Janssen Pharmaceuticals, INC | $696.08 | 2019-2024 | Spravato, Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $693.35 | 2019-2025 | Xifaxan, Trulance |
| Otsuka America Pharmaceutical, INC. | $663.88 | 2019-2025 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $647.87 | 2019-2025 | Jardiance, Synjardy |
| Novo Nordisk INC | $609.22 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Allergan, INC. | $592.58 | 2019-2020 | |
| Bausch Health US, LLC | $590.68 | 2019-2025 | Aplenzin, Wellbutrin |
| Novartis Pharmaceuticals Corporation | $518.89 | 2019-2025 | |
| Lilly USA, LLC | $457.93 | 2019-2025 | Jardiance, Zepbound, Mounjaro |
Show all 97 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $436.03 | 2023-2025 | Caplyta |
| Bayer Healthcare Pharmaceuticals INC. | $431.51 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $399.11 | 2020-2024 | Austedo Xr, Ajovy |
| Almatica Pharma LLC | $380.37 | 2021-2024 | Loreev Xr, Gralise, Teriparatide |
| Merck Sharp & Dohme LLC | $377.66 | 2019-2025 | Gardasil 9, Capvaxive, Belsomra |
| Antares Pharma, INC. | $336.99 | 2019-2025 | Xyosted |
| Lundbeck LLC | $330.39 | 2022-2025 | Rexulti |
| Ironshore Pharmaceuticals INC. | $325.96 | 2019-2023 | Jornay Pm |
| Astellas Pharma US INC | $279.55 | 2019-2025 | Veozah |
| Biohaven Pharmaceuticals, INC. | $273.33 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $259.34 | 2019-2025 | |
| Neurocrine Biosciences, INC. | $258.02 | 2019-2025 | Ingrezza |
| Takeda Pharmaceuticals U.S.A., INC. | $254.93 | 2019-2025 | Trintellix |
| Exact Sciences Corporation | $237.63 | 2023-2025 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $229.54 | 2022 | |
| Adlon Therapeutics L.P. | $204.38 | 2019-2021 | |
| Axsome Therapeutics, INC. | $194.63 | 2024-2025 | Auvelity |
| Eisai INC. | $191.57 | 2020-2022 | |
| Corium, LLC | $181.70 | 2022-2024 | Azstarys |
| Sanofi Pasteur INC. | $175.28 | 2019-2024 | |
| Ibsa Pharma INC. | $165.13 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $160.23 | 2019-2025 | Evkeeza |
| E.R. Squibb & Sons, L.L.C. | $157.42 | 2019-2022 | |
| Alfasigma USA, INC. | $135.17 | 2020-2022 | |
| Arbor Pharmaceuticals, INC. | $134.03 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $133.80 | 2023-2025 | Gemtesa |
| Verity Pharmaceuticals INC. | $104.77 | 2024-2025 | Tlando |
| Endo Pharmaceuticals INC. | $96.30 | 2019 | |
| Alkermes, INC. | $92.28 | 2020-2023 | Aristada, Lybalvi |
| Mayne Pharma Commercial LLC | $90.80 | 2023-2025 | |
| Therapeuticsmd, INC. | $86.02 | 2019-2022 | |
| Biogen, INC. | $83.90 | 2025 | Zurzuvae, Spinraza |
| Nestle Healthcare Nutrition INC. | $83.52 | 2021-2023 | |
| Indivior INC. | $79.18 | 2024-2025 | Sublocade |
| Viiv Healthcare Company | $76.47 | 2025 | Apretude |
| Amarin Pharma, INC. | $74.53 | 2019-2022 | |
| Abbott Laboratories | $73.50 | 2022-2025 | Freestyle Libre 3 |
| Currax Pharmaceuticals LLC | $72.82 | 2023-2025 | Contrave |
| Boston Scientific Corporation | $62.79 | 2025 | Watchman Flx |
| Kowa Pharmaceuticals America, INC. | $62.52 | 2023-2025 | Livalo, Seglentis, Zoryve |
| Azurity Pharmaceuticals, INC. | $60.97 | 2024-2025 | Horizant, Alvesco |
| Vanda Pharmaceuticals INC. | $60.51 | 2024-2025 | Fanapt |
| Eusa Pharma (US) LLC | $60.29 | 2020-2021 | |
| Agios Pharmaceuticals, INC. | $59.01 | 2024-2025 | Pyrukynd |
| Harmony Biosciences LLC | $57.82 | 2023 | Wakix |
| Horizon Therapeutics Plc | $57.06 | 2019 | |
| Tris Pharma INC | $51.55 | 2019-2024 | Dyanavel Xr |
| Aimmune Therapeutics, INC. | $49.83 | 2025 | Zenpep |
| Acadia Pharmaceuticals INC | $49.61 | 2019-2023 | Daybue |
| Bioventus LLC | $49.27 | 2019-2022 | |
| Biomarin Pharmaceutical INC. | $48.08 | 2025 | Voxzogo 1.2mg |
| Scilex Pharmaceuticals INC. | $47.23 | 2019-2023 | Ztlido |
| Shire North American Group INC | $42.18 | 2019 | |
| Genzyme Corporation | $39.08 | 2023 | |
| Phathom Pharmaceuticals, INC. | $38.59 | 2024 | Voquezna |
| Hologic Sales and Service, LLC | $37.19 | 2019-2020 | |
| Ultragenyx Pharmaceutical INC. | $36.80 | 2020-2021 | |
| Vbi Vaccine (Delaware) INC. | $35.67 | 2022 | |
| Genentech USA, INC. | $33.79 | 2019-2021 | |
| Daiichi Sankyo INC. | $31.20 | 2020 | |
| Impulse Dynamics (USA) INC. | $30.72 | 2022 | |
| Gilead Sciences, INC. | $30.58 | 2025 | |
| Kyowa Kirin, INC. | $29.61 | 2025 | |
| Ardelyx, INC. | $28.62 | 2025 | Ibsrela |
| Kaleo, INC. | $28.23 | 2021 | |
| Optinose US, INC. | $23.48 | 2024 | |
| Organon LLC | $22.69 | 2025 | Nexplanon |
| Tactile Systems Technology INC | $22.14 | 2023 | Flexitouch Plus, Entre Plus |
| Medtronic, INC. | $21.32 | 2023 | Venaseal |
| Coopersurgical, INC. | $21.30 | 2025 | Paragard T 380a |
| Supernus Pharmaceuticals, INC. | $20.60 | 2022 | Xyosted |
| Edwards Lifesciences Corporation | $19.68 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Dynavax Technologies Corporation | $19.61 | 2025 | Heplisav-B |
| Halozyme INC | $19.40 | 2023 | |
| Fidia Pharma USA INC. | $18.25 | 2025 | Triluron |
| Becton, Dickinson and Company | $16.87 | 2024 | |
| Inspire Medical Systems, INC. | $16.31 | 2025 | Inspire |
| Optos, INC. | $15.51 | 2021 | |
| Ironwood Pharmaceuticals, INC | $13.66 | 2021 | |
| Medline Industries LP | $13.05 | 2019 | |
| Dermira, INC. | $12.82 | 2020 | |
| Clarus Therapeutics INC. | $10.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Reginato listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.